Add Company
Join Now

Deka BioSciences Revenue and Competitors

License our Company Data API

Rockville,

Location

#2110

Growjo Ranking

Biotech

Industry
Embed

Estimated Revenue & Valuation

  • Deka BioSciences's estimated annual revenue is currently $8.1M per year.(i)
  • Deka BioSciences's estimated revenue per employee is $237,059

Employee Data

  • Deka BioSciences has 34 Employees.(i)
  • Deka BioSciences grew their employee count by -15% last year.

Deka BioSciences's People

NameTitleEmail/Phone
1
Co-founder & CBOReveal Email/Phone
2
VP, Developmental SciencesReveal Email/Phone
3
VP Technical OperationsReveal Email/Phone
4
VP, Clinical OperationsReveal Email/Phone
5
General CounselReveal Email/Phone
6
VP Clinical OperationsReveal Email/Phone
7
Clinical Project DirectorReveal Email/Phone
8
Associate DirectorReveal Email/Phone
9
Chief Operations OfficerReveal Email/Phone
10
Chief Medical OfficerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$81.4M37540%N/AN/A
#2
$16.9M10922%N/AN/A
#3
$156.1M120-70%$145MN/A
#4
$2.9M37-24%$150MN/A
#5
$1.3M170%$459.5MN/A
#6
$49.2M25415%$180.7MN/A
#7
$7M45-2%N/AN/A
#8
$256.3M8409%$168.5MN/A
#9
$4.2M15-32%N/AN/A
#10
$10.1M48-9%N/AN/A
Add Company

What Is Deka BioSciences?

Deka Biosciences, Inc., is an early-stage biotechnology company focused on generating the next generation targeted cytokine therapies to treat cancer and inflammatory diseases. Deka is developing the dual cytokine, (DiakineTM) platform. Diakines are comprised of optimized, stimulatory, or suppressive disease specific IL-10 variants coupled to other stimulatory or suppressive cytokines via a T1/2 life extending tissue targeting, non-immunogenic scFv technology.

keywords:N/A

N/A

Total Funding

34

Number of Employees

$8.1M

Revenue (est)

-15%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$2.6M34-8%$14.4M
#2
$2.7M340%N/A
#3
$6.5M34-8%N/A
#4
$3.5M3413%N/A
#5
$6.7M3410%N/A